Nu-Med Plus (NUMD) Cash & Equivalents (QoQ) (2012 - 2025)
Nu-Med Plus (NUMD) Cash & Equivalents (QoQ) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.88 Bn | 176.59 Bn | 6.27 Bn |
| 2 | Stryker | 128.94 Bn | 126.06 Bn | 3.81 Bn |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.65 Bn | 67.19 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.22 Bn | 44.55 Bn | 1.29 Bn |
| 6 | Dexcom | 28.43 Bn | 27.31 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.32 Bn | 26.03 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 25.10 Bn | 21.98 Bn | 2.07 Bn |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -66.07% |
| Sep 30, 2025 | 125.72% |
| Jun 30, 2025 | -63.63% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | -41.28% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | -36.42% |
| Mar 31, 2024 | -6.61% |
| Dec 31, 2023 | -38.62% |
| Sep 30, 2023 | -62.99% |
| Jun 30, 2023 | -43.51% |
| Mar 31, 2023 | -27.55% |
| Dec 31, 2022 | 11,555.25% |
| Mar 31, 2022 | -78.27% |
| Dec 31, 2021 | -63.33% |
| Sep 30, 2021 | -56.28% |
| Jun 30, 2021 | -47.70% |
| Mar 31, 2021 | -26.12% |
| Dec 31, 2020 | 498.47% |
| Sep 30, 2020 | 415.85% |